2.Effect of methyl eugenol on hypoxia/reoxygenation injury of human renal tubular epithelial cells and its mechanism.
Bai-Cheng KUANG ; Shuai-Heng HOU ; G Ji ZHAN ; Meng-Qin WANG ; Jia-Si ZHANG ; Kai-Lun SUN ; Zhi-Heng WANG ; Qing-Wen LI ; Nian-Qiao GONG
China Journal of Chinese Materia Medica 2021;46(24):6502-6510
This study aimed to investigate the effect of methyl eugenol(ME) on hypoxia/reoxygenation(H/R)-induced injury of human renal tubular epithelial HK-2 cells and its mechanism. The viability of HK-2 cells cultured with different concentrations of ME and exposed to H/R was detected by cell counting kit-8(CCK-8) assay. The effect of ME on the morphology of HK-2 cells was observed under an inverted microscope. The content of intracellular reactive oxygen species in different groups was detected after 2',7'-dichlorodihydrofluorescein diacetate(DCFH-DA) fluorescence staining. Cell apoptosis was determined by flow cytometry. Changes in mitochondrial membrane potential were monitored by JC-1 dye. The concentrations of nuclear factor erythroid 2 related factor 2(Nrf2), heme oxygenase-1(HO-1), and nicotinamide adenine dinucleotide phosphatase oxidase 4(Nox4) were measured by Western blot, followed by the assay of Nrf2 concentration changes in cytoplasm and nucleus by confocal fluorescence staining. The results showed that when the concentration of ME was 0-40 μmol·L~(-1), the activity of HK-2 cells was not affected. Compared with the model group, ME enhanced the activity of HK-2 cells and the cell morphology was normal. As revealed by further experiments, ME inhibited the release of reactive oxygen species and the decline in mitochondrial membrane potential of HK-2 cells after H/R injury, promoted Nrf2/HO-1 expression and Nrf2 translocation to the nucleus, and down-regulated the expression of Nox4, thereby significantly reducing apoptosis. This protective effect of ME could be reversed by the specific Nrf2 inhibitor ML385. These findings have preliminarily proved that ME effectively protected HK-2 cells against H/R injury, which might be related to its promotion of Nrf2/HO-1 signaling pathway and inhibition of Nox4. Such exploration on the possible mechanism of ME in the treatment of renal ischemia-reperfusion injury(IRI) and protection of organ function from the perspective of antioxidant stress has provided reference for related research on the treatment of acute kidney injury with traditional Chinese medicine.
Apoptosis
;
Epithelial Cells/metabolism*
;
Eugenol/pharmacology*
;
Heme Oxygenase-1/metabolism*
;
Humans
;
Hypoxia
;
NF-E2-Related Factor 2/metabolism*
;
Oxidative Stress
;
Reactive Oxygen Species
;
Reperfusion Injury/drug therapy*
3.Effect of methyleugenol on expression of MUC5AC in nasal mucosa of rats with allergic rhinitis.
Nannan MENG ; Yun HOU ; Yan GUI ; Kehu XI ; Youhu WANG ; Jing YANG ; Hong CHEN ; Xiaobing ZHANG
Journal of Zhejiang University. Medical sciences 2016;45(5):477-485
To investigate the effect of methyleugenol on expression of MUC5AC in nasal mucosa of rats with allergic rhinitis (AR).Seventy-two Wistar rats were randomly divided into 6 groups:normal control group, AR group, loratadine group, low-dose methyleugenol group, middle-dose methyleugenol group and high-dose methyleugenol group with 12 rats in each group. AR was induced by intraperitoneal injection of ovalbumin in latter 5 groups. 10 mg loratadine q.d was given to rats in loratadine group by gavage; and 10 mg/kg, 20 mg/kg and 40 mg/kg methyleugenol were given by gavege q.d to rats in low-, middle-and high-dose methyleugenol groups, respectively. Nasal mucosa samples were obtained from rats at 1, 2, 4 and 6 weeks after drug intervention. The expression of MUC5AC protein and mRNA in nasal mucosa was detected by immunohistochemistry and real-time fluorescence quota PCR (RT-PCR), respectively.Compared with AR, the percentage of cells staining positively for MUC5AC protein and the relative quantity of MUC5AC mRNA in middle-and high-dose methyleugenol groups were significantly decreased after 2 and 4 weeks of drug intervention (<0.05), but no such decrease was observed in low-dose methyleugenol group at all time points (>0.05). The percentage of cells with positive expression of MUC5AC protein and mRNA in loratadine group were significantly decreased after 1 week of administration (<0.05). The percentage of cells with positive MUC5AC protein in middle-dose methyleugenol group was higher than that in loratadine group (<0.05) after 6 week of drug intervention, but the difference was not seen in high-dose group (>0.05). There was no significant difference in relative quantities of MUC5AC mRNA after 4 weeks of administration between high-and middle-dose methyeugenol groups and loratadine group (>0.05).Methyleugenol can attenuate AR through inhibiting the expression of MUC5AC mRNA and protein in nasal mucosa of AR rats.
Animals
;
Dose-Response Relationship, Drug
;
Down-Regulation
;
drug effects
;
Eugenol
;
analogs & derivatives
;
pharmacology
;
Loratadine
;
Mucin 5AC
;
drug effects
;
physiology
;
Nasal Mucosa
;
chemistry
;
Ovalbumin
;
Rats
;
Rats, Sprague-Dawley
;
Rats, Wistar
;
Rhinitis, Allergic
;
chemically induced
;
drug therapy
;
physiopathology
4.Screening and analysis of key active constituents in Guanxinshutong capsule using mass spectrum and integrative network pharmacology.
Feng LIU ; Xia DU ; Pei-Rong LIU ; Yu-Hong SUN ; Yan-Min ZHANG
Chinese Journal of Natural Medicines (English Ed.) 2018;16(4):302-312
Guanxinshutong capsule (GXSTC) is an effective and safe traditional Chinese medicine used in the treatment of cardiovascular diseases (CVDs) for many years. However, the targets of this herbal formula and the underlying molecular mechanisms of action involved in the treatment of CVDs are still unclear. In the present study, we used a systems pharmacology approach to identify the active ingredients of GXSTC and their corresponding targets in the calcium signaling pathway with respect to the treatment of CVDs. This method integrated chromatographic techniques, prediction of absorption, distribution, metabolism, and excretion, analysis using Kyoto Encyclopedia of Genes and Genomes, network construction, and pharmacological experiments. 12 active compounds and 33 targets were found to have a role in the treatment of CVDs, and four main active ingredients, including protocatechuic acid, cryptotanshinone, eugenol, and borneol were selected to verify the effect of (GXSTC) on calcium signaling system in cardiomyocyte injury induced by hypoxia and reoxygenation. The results from the present study revealed the active components and targets of GXSTC in the treatment of CVDs, providing a new perspective to enhance the understanding of the role of the calcium signaling pathway in the therapeutic effect of GXSTC.
Animals
;
Animals, Newborn
;
Camphanes
;
chemistry
;
Cardiotonic Agents
;
chemistry
;
pharmacology
;
Cells, Cultured
;
Drugs, Chinese Herbal
;
chemistry
;
pharmacology
;
Eugenol
;
chemistry
;
Gene Expression
;
drug effects
;
Hydroxybenzoates
;
chemistry
;
Mass Spectrometry
;
Models, Biological
;
Myocytes, Cardiac
;
drug effects
;
Nitric Oxide Synthase Type III
;
genetics
;
Phenanthrenes
;
chemistry
;
Rats
;
Rats, Sprague-Dawley
;
Receptor, PAR-1
;
genetics
;
Systems Biology
5.Growth inhibitory response and ultrastructural modification of oral-associated candidal reference strains (ATCC) by Piper betle L. extract.
Mohd-Al-Faisal NORDIN ; Wan Himratul-Aznita Wan HARUN ; Fathilah Abdul RAZAK ; Md Yusoff MUSA
International Journal of Oral Science 2014;6(1):15-21
Candida species have been associated with the emergence of strains resistant to selected antifungal agents. Plant products have been used traditionally as alternative medicine to ease mucosal fungal infections. This study aimed to investigate the effects of Piper betle extract on the growth profile and the ultrastructure of commonly isolated oral candidal cells. The major component of P. betle was identified using liquid chromatography-mass spectrophotometry (LC-MS/MS). Seven ATCC control strains of Candida species were cultured in yeast peptone dextrose broth under four different growth environments: (i) in the absence of P. betle extract; and in the presence of P. betle extract at respective concentrations of (ii) 1 mg⋅mL(-1); (iii) 3 mg⋅mL(-1); and (iv) 6 mg⋅mL(-1). The growth inhibitory responses of the candidal cells were determined based on changes in the specific growth rates (µ). Scanning electron microscopy (SEM) was used to observe any ultrastructural alterations in the candida colonies. LC-MS/MS was performed to validate the presence of bioactive compounds in the extract. Following treatment, it was observed that the µ-values of the treated cells were significantly different than those of the untreated cells (P<0.05), indicating the fungistatic properties of the P. betle extract. The candidal population was also reduced from an average of 13.44×10(6) to 1.78×10(6) viable cell counts (CFU)⋅mL(-1). SEM examination exhibited physical damage and considerable morphological alterations of the treated cells. The compound profile from LC-MS/MS indicated the presence of hydroxybenzoic acid, chavibetol and hydroxychavicol in P. betle extract. The effects of P. betle on candida cells could potentiate its antifungal activity.
Antifungal Agents
;
pharmacology
;
Candida
;
drug effects
;
growth & development
;
ultrastructure
;
Candida albicans
;
drug effects
;
growth & development
;
ultrastructure
;
Candida glabrata
;
drug effects
;
growth & development
;
ultrastructure
;
Candida tropicalis
;
drug effects
;
growth & development
;
ultrastructure
;
Chromatography, Liquid
;
methods
;
Colony Count, Microbial
;
Culture Media
;
Eugenol
;
analogs & derivatives
;
analysis
;
Humans
;
Hydroxybenzoates
;
analysis
;
Microbial Viability
;
drug effects
;
Microscopy, Electron, Scanning
;
Mouth
;
microbiology
;
Phytotherapy
;
Piper betle
;
chemistry
;
Plant Extracts
;
analysis
;
pharmacology
;
Spectrophotometry
;
methods
;
Tandem Mass Spectrometry
;
methods
;
Time Factors